Literature DB >> 18314426

Citing serious risks, FDA recommends no cold and cough medicines for infants.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18314426     DOI： 10.1001/jama.299.8.887

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age.

Authors:  E Fatma Sen; Katia M C Verhamme; Mariagrazia Felisi; Geert W 't Jong; Carlo Giaquinto; Gino Picelli; Adriana Ceci; Miriam C J M Sturkenboom
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

2.  Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Authors:  Robbie L McLeod; Deen B Tulshian; Donald C Bolser; Geoffrey B Varty; Marco Baptista; Xiomara Fernandez; Leonard E Parra; Jennifer C Zimmer; Christine H Erickson; Ginny D Ho; Yanlin Jia; Fay W Ng; Walter Korfmacher; Xiaoying Xu; John Veals; April Smith-Torhan; Samuel Wainhaus; Ahmad B Fawzi; Theodore M Austin; Margaret van Heek; John A Hey
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

3.  Physician and parent response to the FDA advisory about use of over-the-counter cough and cold medications.

Authors:  Jane M Garbutt; Randall Sterkel; Christina Banister; Carrie Walbert; Robert C Strunk
Journal:  Acad Pediatr       Date:  2009-10-12       Impact factor: 3.107

4.  Physician's prescription pattern in young infants with upper respiratory infections/cough and cold in emergency department.

Authors:  Caner Turan; Ali Yurtseven; Eylem Ulas Saz
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.